Business Description
Iovance Biotherapeutics is a California-based company that develops cancer treatments using a patient's own immune cells, which are extracted, grown in large numbers, and returned to the body to fight tumors. Its flagship product, Amtagvi, is approved for advanced melanoma, while its broader pipeline targets several other hard-to-treat cancers including lung, cervical, and head and neck cancers. The company works alongside prominent partners such as the National Cancer Institute, Novartis, and Boehringer Ingelheim to advance its research and expand its reach both in the United States and abroad.
